Last Updated: Wednesday, July 16, 2014, 16:25
The recent National Pharmaceutical Pricing Authority (NPPA) order bringing in some more medicines under control may not have much impact on city-based drug maker Dr Reddy's Laboratories in terms of product pricing, according to a senior company official.
Last Updated: Friday, June 27, 2014, 15:46
Drug maker Dr Reddy's Laboratories has launched duloxetine delayed-release capsules USP 20 mg, 30 mg and 60 mg in the US market.
Last Updated: Wednesday, June 25, 2014, 13:32
Drug firm Dr Reddy's Laboratories has launched generic Paricalcitol capsules used for treating secondary hyperparathyroidism associated with chronic kidney disease in the American market, following approval by the US health regulator.
Last Updated: Wednesday, April 16, 2014, 14:46
The company has started selling 1 mg, 2 mg and 3 mg tablets of Eszopiclone.
Last Updated: Sunday, March 30, 2014, 16:13
After shrugging off its proposed joint venture with Fujifilm which was a non-starter, Dr Reddy's Laboratories Limited is back on the drawing board and is keen to make a fresh foray into the Japanese market.
Last Updated: Thursday, March 13, 2014, 14:20
Dr Reddy's Laboratories has recalled 58,656 bottles of its heartburn drug Lansoprazole in the United States due to a microbial contamination.
Last Updated: Wednesday, March 05, 2014, 14:53
Dr Reddy's Laboratories Ltd has launched Moxifloxacin Hydrochloride tablets in the US market for the treatment of a wide range of diseases, including pneumonia, bronchitis and skin infections.
Last Updated: Monday, November 04, 2013, 17:41
Country's largest drug maker Dr Reddy's Laboratories is set to take its complex generic drug Fondaparinux sodium injection to Canada and two other emerging markets.
Last Updated: Thursday, October 31, 2013, 15:54
Drug major Dr Reddy's Laboratories today reported a 69.41 percent increase in consolidated net profit at Rs 690.25 crore for the second quarter ended September 30.
Last Updated: Friday, September 27, 2013, 12:21
United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd would infringe on the patent of Sunovion Pharmaceuticals blockbuster drug Lunesta.
Last Updated: Tuesday, July 30, 2013, 16:33
Drug maker Dr Reddy's Laboratories Tuesday said its net profit rose by over seven percent to Rs 361 crore for the quarter ended June 30, primarily driven by North American revenues.
Last Updated: Monday, June 03, 2013, 13:47
Though the Memorandum of Understanding for generic drugs has been cancelled, both the companies will explore partnerships in other related areas, said a statement issued by DRL.
more videos >>